Subgroup analysis and other (mis)uses of baseline data in clinical trials
Abstract
Background Baseline data collected on each patient at randomisation in controlled clinical trials can be used to describe the population of patients, to assess comparability of treatment groups, to achieve balanced randomisation, to adjust treatment comparisons for prognostic factors, and to undertake subgroup analyses. We assessed the extent and quality of such practices in major clinical trial reports.Methods A sample of 50 consecutive clinical-trial reports was obtained from four major medical journals during July to September, 1997. We tabulated the detailed information on uses of baseline data by use of a standard form.Findings Most trials presented baseline comparability in a table. These tables were often unduly large, and about half the trials inappropriately used significance tests for baseline comparison. Methods of randomisation, including possible stratification, were often poorly described. There was little consistency over whether to use covariate adjustment and the criteria for selecting baseline factors for which to adjust were often unclear. Most trials emphasised the simple unadjusted results and covariate adjustment usually made negligible difference. Two-thirds of the reports presented subgroup findings, but mostly without appropriate statistical tests for interaction. Many reports put too much emphasis on subgroup analyses that commonly lacked statistical power.Interpretation Clinical trials need a predefined statistical analysis plan for uses of baseline data, especially covariate-adjusted analyses and subgroup analyses. Investigators and journals need to adopt improved standards of statistical reporting, and exercise caution when drawing conclusions from subgroup findings.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Each model considered baseline factors differing between treatment arms and associated with the outcome, preserving statistical power and ensuring precise 95% confidence intervals.
“Additionally, each model considered baseline factors differing between treatment arms and associated with the outcome [73], preserving statistical power and ensuring precise 95% confidence intervals [74].”
From Can an Acceptance and Commitment Therapy-Based Smartphone App Help Individuals with Mental Health Disorders Quit Smoking? (2024) · cites this paper as [73]
In a review of 50 RCTs in high-impact journals, 70% of trials tested interactions.
“In 2000, Assmann et al 3 reviewed 50 RCTs in high-impact journals and found that 70% of trials tested interactions, but only 43% of the studies testing interaction reported the test they used, and 37% of them reported P-values only.”
From Understanding of interaction (subgroup) analysis in clinical trials (2019) · cites this paper as [3]
Among studies testing interaction, only 43% reported the test they used.
“In 2000, Assmann et al 3 reviewed 50 RCTs in high-impact journals and found that 70% of trials tested interactions, but only 43% of the studies testing interaction reported the test they used, and 37% of them reported P-values only.”
From Understanding of interaction (subgroup) analysis in clinical trials (2019) · cites this paper as [3]
37% of studies testing interaction reported P-values only.
“In 2000, Assmann et al 3 reviewed 50 RCTs in high-impact journals and found that 70% of trials tested interactions, but only 43% of the studies testing interaction reported the test they used, and 37% of them reported P-values only.”
From Understanding of interaction (subgroup) analysis in clinical trials (2019) · cites this paper as [3]
Cites
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127 · see citing works
Clinical Trials: A Practical Approach.
Hill, I. D., & Pocock, S. (1984) · Biometrics · doi:10.2307/2531186 · Cited by 2,918 · see citing works
Self-citationComparison of coronary bypass surgery with angioplasty in patients with multivessel disease.
Bourassa, M., Frye, R., King, S., Detre, K., Alderman, E., Andrews, K., & Sopko, G. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350401 · Cited by 1,489 · see citing works
Olds, D. L. (1997) · JAMA · doi:10.1001/jama.1997.03550080047038 · Cited by 1,372 · see citing works
Yusuf, S. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470010097038 · Cited by 1,014 · see citing works
Appointment of New Associate Editor for Circulation
Willerson, J. (1996) · Circulation · doi:10.1161/01.cir.94.6.1193 · Cited by 918 · see citing works
Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome
van der Horst, C. M., Saag, M. S., Cloud, G. A., Hamill, R. J., Graybill, J. R., Sobel, J. D., Johnson, P. C., Tuazon, C. U., Kerkering, T. M., Moskovitz, B. L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707033370103 · Cited by 808 · see citing works
Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism
The Columbus Investigators (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371001 · Cited by 788 · see citing works
Statistical Problems in the Reporting of Clinical Trials
Pocock, S., Hughes, M. D., & Lee, R. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708133170706 · Cited by 660 · see citing works
Self-citationKostis, J. B. (1997) · JAMA · doi:10.1001/jama.278.3.212 · Cited by 620 · see citing works
Frison, L., & Pocock, S. J. (1992) · Statistics in Medicine · doi:10.1002/sim.4780111304 · Cited by 593 · see citing works
Self-citationRolfs, R. T., Joesoef, M. R., Hendershot, E. F., Rompalo, A. M., Augenbraun, M. H., Chiu, M., Bolan, G., Johnson, S. C., French, P., Steen, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370504 · Cited by 550 · see citing works
Senn, S. J., Frison, L., & Pocock, S. (1994) · Statistics in Medicine · doi:10.1002/sim.4780130210 · Cited by 529 · see citing works
Self-citationSchulz, K. F. (1994) · JAMA · doi:10.1001/jama.1994.03520020051014 · Cited by 514 · see citing works
Randomisation and baseline comparisons in clinical trials
Altman, D. G., & Doré, C. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)90014-v · Cited by 508 · see citing works
Testing for baseline balance in clinical trials
Senn, S. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131703 · Cited by 503 · see citing works
Kostis, J. B. (1997) · JAMA · doi:10.1001/jama.1997.03550030052033 · Cited by 495 · see citing works
Frasure-Smith, N., Lespérance, F., Prince, R. H., Verrier, P., Garber, R. A., Juneau, M., Wolfson, C., & Bourassa, M. G. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02142-9 · Cited by 461 · see citing works
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis
Christensen, E., Neuberger, J., Crowe, J., Altman, D. G., Pópper, H., Portmann, B. C., Doniach, D., Ranek, L., Tygstrup, N., & Williams, R. L. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90213-6 · Cited by 423 · see citing works
Some Surprising Results about Covariate Adjustment in Logistic Regression Models
Robinson, L. D., & Jewell, N. P. (1991) · International Statistical Review · doi:10.2307/1403444 · Cited by 410 · see citing works
Comparability of Randomised Groups
Altman, D. G. (1985) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2987510 · Cited by 329 · see citing works
Covariate imbalance and random allocation in clinical trials
Senn, S. J. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080410 · Cited by 281 · see citing works
Sundberg, K., Bang, J., Smidt‐Jensen, S., Brocks, V., Lundsteen, C., Parner, J., Keiding, N., & Philip, J. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02449-5 · Cited by 185 · see citing works
Low-Molecular-Weight Heparin in the Treatment of Patients With Venous Thromboembolism
(1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)63665-6 · Cited by 171 · see citing works
Gordin, F. M., Matts, J. P., Miller, C., Brown, L. S., Hafner, R., John, S. L., Klein, M., Vaughn, A., Besch, C. L., Pérez, G. V., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370505 · Cited by 166 · see citing works
Freedman, L. S., & White, S. J. (1976) · Biometrics · doi:10.2307/2529759 · Cited by 131 · see citing works
Choosing covariates in the analysis of clinical trials
Beach, M. L., & Meier, P. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90055-x · Cited by 103 · see citing works
Model inconsistency, illustrated by the cox proportional hazards model
Ford, I., Norrie, J. D., & Ahmadi, S. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140804 · Cited by 97 · see citing works
Adaptive allocation in randomized controlled trials
Birkett, N. (1985) · Controlled Clinical Trials · doi:10.1016/0197-2456(85)90120-5 · Cited by 79 · see citing works
Practical experience of randomization in cancer trials: an international survey
Pocock, S., & Lagakos, S. W. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.212 · Cited by 37 · see citing works
Self-citationA simple method for converting an odds ratio to effect size for use in meta-analysis
Chinn, S. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20001130)19:22
Flagged first, then by citations
Cited by
Sorted by citations
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835 · see citing works
How should meta‐regression analyses be undertaken and interpreted?
Thompson, S. G., & Higgins, J. P. T. (2002) · Statistics in Medicine · doi:10.1002/sim.1187 · Cited by 3,026 · see citing works
Estimation and Inference of Heterogeneous Treatment Effects using Random Forests
Wager, S., & Athey, S. (2018) · Journal of the American Statistical Association · doi:10.1080/01621459.2017.1319839 · Cited by 2,917 · see citing works
Spironolactone for heart failure with preserved ejection fraction
Pitt, B., Pfeffer, M. A., Assmann, S. F., Boineau, R., Anand, I. S., Claggett, B., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313731 · Cited by 2,809 · see citing works
Self-citationMoher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2011.10.001 · Cited by 2,345 · see citing works
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., & Loder, E. (2013) · Value in Health · doi:10.1016/j.jval.2013.02.002 · Cited by 1,998 · see citing works
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924 · see citing works
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.03.004 · Cited by 1,858 · see citing works
Interpretation of the evidence for the efficacy and safety of statin therapy
Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857 · see citing works
Statistics in Medicine — Reporting of Subgroup Analyses in Clinical Trials
Wang, R., Lagakos, S. W., Ware, J. H., Hunter, D. J., & Drazen, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr077003 · Cited by 1,445 · see citing works
Pocock, S. J., Assmann, S. E., Enos, L. E., & Kasten, L. E. (2002) · Statistics in Medicine · doi:10.1002/sim.1296 · Cited by 1,077 · see citing works
Self-citationSubgroup analysis in randomised controlled trials: importance, indications, and interpretation
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17709-5 · Cited by 942 · see citing works
Bolland, M. J., Grey, A., Avenell, A., Gamble, G. D., & Reid, I. R. (2011) · BMJ · doi:10.1136/bmj.d2040 · Cited by 851 · see citing works
Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses
Sun, X., Briel, M., Walter, S. D., & Guyatt, G. H. (2010) · BMJ · doi:10.1136/bmj.c117 · Cited by 808 · see citing works
Schandelmaier, S., Briel, M., Varadhan, R., Schmid, C. H., Devasenapathy, N., Hayward, R. A., Gagnier, J., Borenstein, M., van der Heijden, G. J. M. G., Dahabreh, I. J., et al. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.200077 · Cited by 749 · see citing works
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Value in Health · doi:10.1016/j.jval.2021.10.008 · Cited by 847 · see citing works
Guidelines for Controlled Trials of Drugs in Migraine: Second Edition
International Headache Society Clinical Trials Subcommittee, Tfelt-Hansen, P., Block, G., Dahlöf, C., Diener, H.-C., Ferrari, M., Goadsby, P., Guidetti, V, Jones, B., Lipton, R., et al. (2000) · Cephalalgia · doi:10.1046/j.1468-2982.2000.00117.x · Cited by 698 · see citing works
Stuck, A. E., Egger, M., Hammer, A., Minder, C. E., & Beck, J. C. (2002) · JAMA · doi:10.1001/jama.287.8.1022 · Cited by 675 · see citing works
Sud, S., Friedrich, J. O., Taccone, P., Polli, F., Adhikari, N. K. J., Latini, R., Pesenti, A., Guérin, C., Mancebo, J., Curley, M. A. Q., et al. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1748-1 · Cited by 563 · see citing works
Randomized Trials or Observational Tribulations?
Pocock, S. J., & Elbourne, D. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422511 · Cited by 550 · see citing works
Self-citationDesign of Treatment Trials for Functional Gastrointestinal Disorders
Irvine, E. J., Tack, J., Crowell, M. D., Gwee, K. A., Ke, M., Schmulson, M. J., Whitehead, W. E., & Spiegel, B. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.010 · Cited by 550 · see citing works
The Challenge of Subgroup Analyses — Reporting without Distorting
Lagakos, S. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068070 · Cited by 504 · see citing works
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
Kent, D. M., Rothwell, P. M., Ioannidis, J. P., Altman, D. G., & Hayward, R. A. (2010) · Trials · doi:10.1186/1745-6215-11-85 · Cited by 504 · see citing works
Kahan, B. C., Jairath, V., Doré, C. J., & Morris, T. P. (2014) · Trials · doi:10.1186/1745-6215-15-139 · Cited by 497 · see citing works
The Predictive Approaches to Treatment effect Heterogeneity (PATH) statement
Kent, D. M., Paulus, J. K., van Klaveren, D., D'Agostino, R., Goodman, S., Hayward, R., Ioannidis, J. P. A., Patrick-Lake, B., Morton, S., Pencina, M., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m18-3667 · Cited by 469 · see citing works
Multiplicity in randomised trials II: subgroup and interim analyses
Schulz, K. F., & Grimes, D. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66516-6 · Cited by 357 · see citing works
de Boer, M. R., Waterlander, W. E., Kuijper, L. D., Steenhuis, I. H., & Twisk, J. W. (2015) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-015-0162-z · Cited by 370 · see citing works
Issues in the reporting of epidemiological studies: a survey of recent practice.
Pocock, S. J., Collier, T. J., Dandreo, K. J., de Stavola, B. L., Goldman, M. B., Kalish, L. A., Kasten, L. E., & McCormack, V. A. (2004) · BMJ · doi:10.1136/bmj.38250.571088.55 · Cited by 313 · see citing works
Self-citationThree simple rules to ensure reasonably credible subgroup analyses
Burke, J. F., Sussman, J. B., Kent, D. M., & Hayward, R. A. (2015) · BMJ · doi:10.1136/bmj.h5651 · Cited by 312 · see citing works
Rich-Edwards, J. W., Kaiser, U. B., Chen, G. L., Manson, J. E., & Goldstein, J. M. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00246 · Cited by 273 · see citing works
Hernández, A. V., Steyerberg, E. W., & Habbema, J. D. F. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2003.09.014 · Cited by 258 · see citing works
Chan, A.-W., Hrobjartsson, A., Jorgensen, K. J., Gotzsche, P. C., & Altman, D. G. (2008) · BMJ · doi:10.1136/bmj.a2299 · Cited by 202 · see citing works
Dwan, K., Altman, D. G., Clarke, M., Gamble, C., Higgins, J. P. T., Sterne, J. A. C., Williamson, P. R., & Kirkham, J. J. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001666 · Cited by 187 · see citing works
Can meta-analysis help target interventions at individuals most likely to benefit?
Thompson, S. G., & Higgins, J. P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)70200-2 · Cited by 174 · see citing works
Detecting moderator effects using subgroup analyses
Wang, R., & Ware, J. H. (2013) · Prevention Science · doi:10.1007/s11121-011-0221-x · Cited by 165 · see citing works
Knopp, J., Knowles, S., Bee, P., Lovell, K., & Bower, P. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2013.08.008 · Cited by 164 · see citing works
Pincus, T., Miles, C., Froud, R., Underwood, M., Carnes, D., & Taylor, S. J. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-14 · Cited by 161 · see citing works
Mattes, R. D., Shikany, J. M., Kaiser, K. A., & Allison, D. B. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00755.x · Cited by 160 · see citing works
Wallach, J. D., Sullivan, P. G., Trepanowski, J. F., Sainani, K. L., Steyerberg, E. W., & Ioannidis, J. P. A. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9125 · Cited by 148 · see citing works
The Pursuit of Balance Using Stratified and Dynamic Randomization Techniques: An Overview
McEntegart, D. J. (2003) · Drug Information Journal · doi:10.1177/009286150303700305 · Cited by 145 · see citing works
Hodgkins, P., Shaw, M., Coghill, D., & Hechtman, L. (2012) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-012-0286-5 · Cited by 147 · see citing works
N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes
Ezekowitz, J. A., O’Connor, C. M., Troughton, R. W., Alemayehu, W. G., Westerhout, C. M., Voors, A. A., Butler, J., Lam, C. S. P., Ponikowski, P., Emdin, M., et al. (2020) · JACC: Heart Failure · doi:10.1016/j.jchf.2020.08.008 · Cited by 146 · see citing works
Gong, Y., Huang, Z., Christensen, E., & Gluud, C. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01235.x · Cited by 131 · see citing works
Subgroup analyses in therapeutic cardiovascular clinical trials: Are most of them misleading?
Hernández, A. V., Boersma, E., Murray, G. D., Habbema, J. D. F., & Steyerberg, E. W. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.020 · Cited by 131 · see citing works
Understanding of interaction (subgroup) analysis in clinical trials
Brankovic, M., Kardys, I., Steyerberg, E. W., Lemeshow, S., Markovic, M., Rizopoulos, D., & Boersma, E. (2019) · European Journal of Clinical Investigation · doi:10.1111/eci.13145 · Cited by 130 · see citing works
The Physical Activity 4 Everyone Cluster Randomized Trial
Sutherland, R. L., Campbell, E. M., Lubans, D. R., Morgan, P. J., Nathan, N. K., Wolfenden, L., Okely, A. D., Gillham, K. E., Hollis, J. L., Oldmeadow, C. J., et al. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.02.020 · Cited by 118 · see citing works
Marsden, J., Stillwell, G., Barlow, H., Boys, A., Taylor, C., Hunt, N., & Farrell, M. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01290.x · Cited by 117 · see citing works
When One Depends on the Other: Reporting of Interaction in Case-Control and Cohort Studies
Knol, M. J., Egger, M., Scott, P., Geerlings, M. I., & Vandenbroucke, J. P. (2009) · Epidemiology · doi:10.1097/ede.0b013e31818f6651 · Cited by 113 · see citing works
Ougrin, D., Corrigall, R., Poole, J., Zundel, T., Sarhane, M., Slater, V., Stahl, D., Reavey, P., Byford, S., Heslin, M., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30129-9 · Cited by 101 · see citing works
Sargeant, J. M., O’connor, A. M., Gardner, I. A., Dickson, J. S., Torrence, M. E., Dohoo, C. M. P. I. R., Lefebvre, S. L., Morley, P. S., Ramirez, A., & Snedeker, K. (2010) · Journal of Food Protection · doi:10.4315/0362-028x-73.3.579 · Cited by 97 · see citing works
Zhao, W., Hill, M. D., & Palesch, Y. (2015) · Statistical Methods in Medical Research · doi:10.1177/0962280212436447 · Cited by 87 · see citing works
Kallert, T. W., Priebe, S., McCabe, R., Kiejna, A., Rymaszewska, J., Nawka, P., Ocvár, L., Raboch, J., Stárková-Kalisová, L., Koch, R., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0214 · Cited by 92 · see citing works
Wallach, J. D., Sullivan, P. G., Trepanowski, J. F., Steyerberg, E. W., & Ioannidis, J. P. A. (2016) · BMJ · doi:10.1136/bmj.i5826 · Cited by 89 · see citing works
Bilimoria, K. Y., Chung, J. W., Hedges, L. V., Dahlke, A. R., Love, R., Cohen, M. E., Tarpley, J., Mellinger, J., Mahvi, D. M., Kelz, R. R., et al. (2016) · JAMA Surgery · doi:10.1001/jamasurg.2015.4990 · Cited by 87 · see citing works
Believability of relative risks and odds ratios in abstracts: Cross sectional study.
Gøtzsche, P. C. (2006) · BMJ · doi:10.1136/bmj.38895.410451.79 · Cited by 85 · see citing works
Shallcross, A. J., Gross, J. J., Visvanathan, P. D., Kumar, N., Palfrey, A., Ford, B. Q., Dimidjian, S., Shirk, S., Holm-Denoma, J., Goode, K. M., et al. (2015) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000050 · Cited by 81 · see citing works
The importance of long-term follow up of participants in clinical trials
Cuzick, J. (2023) · British Journal of Cancer · doi:10.1038/s41416-022-02038-4 · Cited by 101 · see citing works
General guidance on exploratory and confirmatory subgroup analysis in late-stage clinical trials
Dmitrienko, A., Muysers, C., Fritsch, A., & Lipkovich, I. (2016) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2015.1092033 · Cited by 51 · see citing works
Outcome based subgroup analysis: a neglected concern
Hirji, K. F., & Fagerland, M. W. (2009) · Trials · doi:10.1186/1745-6215-10-33 · Cited by 41 · see citing works
Cruwys, T., Haslam, C., Rathbone, J. A., Williams, E., & Haslam, S. A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.029 · Cited by 37 · see citing works
Variation in results from randomized, controlled trials: stochastic or systematic?
Jane-wit, D., Horwitz, R. I., & Concato, J. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.02.010 · Cited by 33 · see citing works
Schuit, E., Li, A. H., & Ioannidis, J. P. A. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyy239 · Cited by 27 · see citing works
Challenges and Solutions to Pre- and Post-Randomization Subgroup Analyses
Desai, M., Pieper, K. S., & Mahaffey, K. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0531-2 · Cited by 26 · see citing works
Underwood, M., Mistry, D., Lall, R., & Lamb, S. (2011) · Arthritis Care & Research · doi:10.1002/acr.20518 · Cited by 23 · see citing works
Kneipp, S. M., Kairalla, J. A., & Sheely, A. L. (2013) · Social Science & Medicine · doi:10.1016/j.socscimed.2012.08.011 · Cited by 15 · see citing works
Bricker, J. B., Santiago‐Torres, M., Mull, K. E., Sullivan, B. M., David, S. P., Schmitz, J., Stotts, A., & Rigotti, N. A. (2024) · Addiction · doi:10.1111/add.16396 · Cited by 10 · see citing works
Alcohol Use Severity, Anger and Drinking Motives among Firefighters
Miloslavich, K., Leonard, S. J., Wardle, M. C., & Vujanovic, A. A. (2023) · Substance Use & Misuse · doi:10.1080/10826084.2023.2177113 · Cited by 6 · see citing works
Santiago-Torres, M., Mull, K. E., Sullivan, B. M., & Bricker, J. B. (2024) · Substance Use & Misuse · doi:10.1080/10826084.2023.2293732 · Cited by 5 · see citing works
Lukow, P. B., Lowther, M., Pike, A. C., Yamamori, Y., Chavanne, A. V., Gormley, S., Aylward, J., McCloud, T., Goble, T., Rodriguez-Sanchez, J., et al. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241286773 · Cited by 3 · see citing works
“For the follow-up data, equivalent analyses were conducted with R’s lm function, including baseline activation or connectivity maps as a covariate of no interest, a method shown to have the largest power to estimate post-treatment effects (Assmann et al., 2000; Vickers, 2001).”
MethodSantiago-Torres, M., Mull, K. E., Sullivan, B. M., Prochaska, J. J., Zvolensky, M. J., & Bricker, J. B. (2024) · Depression and Anxiety · doi:10.1155/2024/1055801 · Cited by 3 · see citing works
“Additionally, each model considered baseline factors differing between treatment arms and associated with the outcome [73], preserving statistical power and ensuring precise 95 % con fi dence intervals [74].”
- Authors
- Assmann, S. F., Pocock, S. J., Enos, L. E., & Kasten, L. E.
- Affiliations
- New England Research Institutes (US)
- London School of Hygiene & Tropical Medicine (GB)
- Corresponding author
- Pocock, Stuart J
- ORCID
- Pocock, Stuart J
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2000-03
- Volume
- 355
- Issue
- 9209
- Pages
- 1064-1069
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2108233388
- Cited by
- 1,167
- References
- 32
- Citations by year
- 2026: 25 · 2025: 48 · 2024: 35 · 2023: 40 · 2022: 34 · 2021: 40 · 2020: 45 · 2019: 48 · 2018: 38 · 2017: 48 · 2016: 60 · 2015: 51 · 2014: 48 · 2013: 58 · 2012: 53
- FWCI
- 41.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
- Keywords
- baseline data, subgroup analysis, covariate adjustment, clinical trial reporting, statistical reporting standards, randomization, stratification, interaction testing, statistical power, prognostic factors, analysis plan
- MeSH terms
- Data Collection, Data Interpretation, Statistical, Humans, Bias, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review